Aandelen in “Productie van biologische producten”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
Cardiff Oncology Inc |
20/02 | 1,610 USD
-1,23% |
-1,23% |
|
CASI Pharmaceuticals Inc |
20/02 | 0,765 USD
-4,36% |
-4,36% |
|
Cel-Sci Corp. |
20/02 | 4,800 USD
-0,83% |
-0,83% |
|
Celldex Therapeutics Inc. |
20/02 | 23,020 USD
-2,21% |
-2,21% |
|
Cellectis |
20/02 | 3,900 USD
-2,26% |
-2,26% |
Cellectis |
20/02 | 3,440 EUR
+1,18% |
+1,18% |
|
Champions Oncology Inc |
20/02 | 5,820 USD
-3,80% |
-3,80% |
|
Cidara Therapeutics Inc |
6/01 | 221,380 USD
+0,03% |
+0,03% |
|
Coherus Biosciences Inc |
20/02 | 1,630 USD
-4,68% |
-4,68% |
|
CRISPR Therapeutics AG |
20/02 | 53,460 USD
-2,16% |
-2,16% |
|
Curis Inc |
20/02 | 1,110 USD
-2,63% |
-2,63% |
Nieuws over “Productie van biologische producten”
